Partnering

IPC BioInformatics’ initial experiments using HPAPs derived from Malaria, tuberculosis and HIV support its methodology and patent application.

We are seeking interested parties to partner with us to exclusively license our methodology that identifies these HPAPS with the goal to target these and the myriad of other difficult diseases which we have identified HPAPS for but still need to test.

Please contact us for a detailed non-confidential presentation of our overall methodology via Zoom.

To schedule an appointment please contact:

Barton O’Brien
CEO
bart@ipcbio.com